Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
21.07
+0.38 (1.84%)
At close: Jan 9, 2026, 4:00 PM EST
21.12
+0.05 (0.24%)
After-hours: Jan 9, 2026, 7:50 PM EST
Baxter International Market Cap
Baxter International has a market cap or net worth of $10.83 billion as of January 9, 2026. Its market cap has decreased by -27.30% in one year.
Market Cap
10.83B
Enterprise Value
18.82B
1-Year Change
-27.30%
Ranking
Category
Stock Price
$21.07
Market Cap Chart
Since December 1, 1998, Baxter International's market cap has decreased from $18.88B to $10.83B, a decrease of -42.62%. That is a compound annual growth rate of -2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 10.83B | 10.26% |
| Dec 31, 2025 | 9.82B | -34.02% |
| Dec 31, 2024 | 14.89B | -24.09% |
| Dec 29, 2023 | 19.61B | -23.67% |
| Dec 30, 2022 | 25.70B | -40.22% |
| Dec 31, 2021 | 42.98B | 4.86% |
| Dec 31, 2020 | 40.99B | -3.99% |
| Dec 31, 2019 | 42.69B | 21.89% |
| Dec 31, 2018 | 35.03B | -0.55% |
| Dec 29, 2017 | 35.22B | 46.03% |
| Dec 30, 2016 | 24.12B | 15.57% |
| Dec 31, 2015 | 20.87B | -47.46% |
| Dec 31, 2014 | 39.72B | 5.24% |
| Dec 31, 2013 | 37.74B | 3.07% |
| Dec 31, 2012 | 36.62B | 31.26% |
| Dec 30, 2011 | 27.90B | -5.42% |
| Dec 31, 2010 | 29.50B | -16.62% |
| Dec 31, 2009 | 35.38B | 6.44% |
| Dec 31, 2008 | 33.24B | -9.71% |
| Dec 31, 2007 | 36.81B | 21.24% |
| Dec 29, 2006 | 30.36B | 29.31% |
| Dec 30, 2005 | 23.48B | 10.27% |
| Dec 31, 2004 | 21.29B | 14.31% |
| Dec 31, 2003 | 18.63B | 12.13% |
| Dec 31, 2002 | 16.61B | -47.53% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |